Exclusive Acquisition Opportunity

Highly Profitable
Group of
Audiology Clinics

True North M&A presents an opportunity to acquire a premier independent group of clinics in Western Canada — with 6 consecutive years of record revenue growth and a well-established multi-decade operating history.

~$7M

FY2025 Revenue

6th consecutive record year

~$2M

Adj. EBITDA

~28.6% EBITDA margin

~76%

Gross Margin

Average since FY2022

~7%

Revenue CAGR

FY2020–FY2025

Foundational Strengths of this Opportunity

Click any row to expand the full detail behind each competitive strength.

Established Multi-Site Platform

Decades of operating history, consistent performance

›

A multi-site platform with decades of operating history — delivering consistent performance and strong brand recognition across two provinces.

Unparalleled Financial Performance

Strong margins and growth opportunities

›

~7% CAGR with very strong margins and continued growth opportunities.

Strong Local Market Presence

Competitive moat built over decades in Western Canada

›

Well-established presence in Western Canada — creating a competitive moat that would be difficult and costly for new entrants to replicate.

Loyal Customer Base & Long-Standing Relationships

High retention and referral-driven new customer acquisition

›

Long-standing customer relationships drive high retention and referral-led new customer acquisition — a defensible, predictable revenue base.

Predictable Revenue & Replacement Cycles

Resilient revenue stream independent of economic conditions

›

Revenue underpinned by predictable replacement cycles and ongoing service needs — largely independent of broader economic conditions.

Experienced Team, Day-to-Day Continuity

Operational team in place to support ongoing operations

›

An experienced team in place to support day-to-day operations — ensuring smooth transition continuity with minimal disruption.

Revenue & Profitability at a Glance

Six-year performance comprising four years of reviewed actuals and two years of management presented through revenue bars with an Adj. EBITDA margin overlay. A toggle below provides a Gross Margin view.

Revenue HistoricalRevenue ForecastAdj. EBITDA Margin

Adj. EBITDA Growth FY22→FY25

+41%^3yr

Adj. EBITDA CAGR ~12% vs. Revenue CAGR 7% — demonstrating clear operating leverage

FY2027 Organic Projection

$8.14M^proj

Achievable through capacity utilisation alone — before any acquisition activity

Peak Gross Margin

77.6%^FY25

Highest gross margin on record — consistent upward trend from 73.5% in FY2023

Adj. EBITDA Margin

~28.6%^FY25

From $1.39M in FY2022 to $1.96M in FY2025 — strong and consistent profitability

Five Growth Opportunities for the Next Owner

Click any row to expand the full opportunity detail.

Organic Capacity Expansion

~80% utilisation → near-term organic upside

›

Clinics are currently operating at ~80% capacity. Extended hours and additional practitioners can deliver near-term organic revenue growth without significant capital investment.

Further Consolidation via Acquisitions

Fragmented market → clear roll-up opportunity

›

A highly fragmented independent market presents a clear roll-up play. Clinic infrastructure and brand recognition provide an ideal acquisition foundation for continued consolidation.

Geographic Expansion

Western Canadian base → adjacent markets

›

Proven footprint across two provinces provides a strong base for entry into adjacent markets with comparable demographics.

Operational and Process Optimization

Centralised procurement → margin expansion

›

Centralising procurement, marketing and admin across all locations converts overhead savings directly into EBITDA margin — a clear lever for the incoming owner.

Brand Consolidation

Unified identity → scalability & recognition

›

Unifying three brands strengthens digital presence and referral network development — enhancing strategic value, platform narrative and exit optionality.

Structural Tailwinds, Not Economic Cycles

Demand driven by demography, clinical need and government policy.

›

Aging Demographics

~8.1M → ~10.5M

Canadians aged 65+ by 2040

A 30% expansion in the core addressable demographic over 15 years — driven entirely by demographics, not economic cycles.

›

High Clinical Prevalence

~65%

Of 70–79 year-olds affected

Hearing aids are replaced every 4–6 years — creating a deeply embedded, highly predictable repurchase cycle tied to clinical need, not consumer sentiment.

›

Significant Underdiagnosis

↑ Untapped

A large share of hearing loss goes untreated

As primary care referrals, digital screening, and family influence increase, awareness and diagnosis rates are expected to improve, supporting volume growth beyond demographic trends alone.

›

Government-Supported Demand

Gov't Backed

Provincial subsidies reduce price sensitivity

Provincial programs provide a stable government-backed demand floor — insulating the business from consumer spending cycles and supporting higher conversion rates.

Next Steps

Request the Full CIM

To request access to the full Confidential Information Memorandum, please click the request button. You will be directed to complete a short NDA, after which the CIM will be shared.

All enquiries must be directed exclusively through True North M&A. Under no circumstances should prospective buyers contact the business owners, staff, or any associated person directly.

For additional inquiries outside of the NDA and CIM, please contact
jonathan@truenorthma.ca

This teaser has been prepared by True North Mergers & Acquisitions for preliminary evaluation purposes only. Information has not been independently verified. Distribution is strictly limited to authorised recipients.

OpportunityProject Soundcheck

Broker ContactJonathan Wallace

GeographyWestern Canada